PF-06462894

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NamePF-06462894

Drug Alias NamePF-06462894

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMetabotropic glutamate receptor 5 antagonists

TargetsMetabotropic glutamate receptor 5

Therapy Area/IndicationsLevodopa-induced dyskinesia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesPfizer Inc

Inactive CompaniesN/A

Active IndicationsLevodopa-induced dyskinesia

Inactive IndicationsN/A

ATC CodeN/A